Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

September 30, 2015

Conditions
HIV Infection
Interventions
DRUG

atazanavir 300mg boosted with ritonavir 50 mg

"atazanavir 300 mg with ritonavir 100 mg once a day at 8:00 am for study day 1 and 9.~atazanavir 300 mg with ritonavir 50 mg once a day at 8:00 am for 7 consecutive days (study days 2-8)"

Trial Locations (1)

K1H 8L6

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Ottawa Hospital Research Institute

OTHER